Henn, Matthew R.
Seres Therapeutics (United States)
2 papers on CoChatORCID 0000-0001-8734-5797
Most cited papers
- Verified
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Feuerstadt, P., Louie, T. J., Lashner, B., Wang, E. E. L., Diao, L., Bryant, J. A., Sims, M., Kraft, C. S., Cohen, S. H., Berenson, C. S., et al. (2022) · New England Journal of Medicine
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 558
- Verified
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Glitza, I. C., Seo, Y. D., Spencer, C. N., Wortman, J. R., Burton, E. M., Alayli, F. A., Loo, C. P., Gautam, S., Damania, A., Densmore, J., et al. (2024) · Cancer Discovery
Cancer Immunotherapy and BiomarkersGut microbiota and health
Cited by 87
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free